National Securities Downgrades Yield10 Bioscience to Neutral, Lowers Price Target to $0.25

National Securities downgrades Yield10 Bioscience (NASDAQ:YTEN) from Buy to Neutral and lowers the price target from $5 to $0.25.

Benzinga · 11/18/2019 13:43

National Securities downgrades Yield10 Bioscience (NASDAQ:YTEN) from Buy to Neutral and lowers the price target from $5 to $0.25.